product summary
Loading...
company name :
R&D Systems
product type :
other
product name :
TumorTACS In Situ Apoptosis Detection Kit
catalog :
4815-30-K
quantity :
30 Tests
price :
509 USD
more info or order :
citations: 21
Reference
Zhang H, Ren Y, Li H, Zheng C, Qian K. Renal and hepatic artery embolization with Pickering gel emulsion of lipiodol in rabbit. BMC Cancer. 2022;22:1300 pubmed publisher
Kim H, Pyo H, Kim H, Kang H. Multi-Lens Arrays (MLA)-Assisted Photothermal Effects for Enhanced Fractional Cancer Treatment: Computational and Experimental Validations. Cancers (Basel). 2021;13: pubmed publisher
Andreata F, Bonizzi A, Sevieri M, Truffi M, Monieri M, Sitia L, et al. Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model. Sci Rep. 2020;10:11425 pubmed publisher
Tatsumi Y, Miyake M, Shimada K, Fujii T, Hori S, Morizawa Y, et al. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells. Int J Mol Sci. 2020;21: pubmed publisher
Nam S, Kim J. Tussilagone Reduces Tumorigenesis by Diminishing Inflammation in Experimental Colitis-Associated Colon Cancer. Biomedicines. 2020;8: pubmed publisher
Liu X, Hu J, Song X, Utpatel K, Zhang Y, Wang P, et al. Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers (Basel). 2019;11: pubmed publisher
Xu J, Yang S, Gu X, Shen H, Wang L, Xu W, et al. SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma. Exp Mol Pathol. 2019;:104276 pubmed publisher
Guha P, Tyagi R, Chowdhury S, Reilly L, Fu C, Xu R, et al. IPMK Mediates Activation of ULK Signaling and Transcriptional Regulation of Autophagy Linked to Liver Inflammation and Regeneration. Cell Rep. 2019;26:2692-2703.e7 pubmed publisher
Kalainayakan S, Ghosh P, Dey S, FitzGerald K, Sohoni S, Konduri P, et al. Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression. Sci Rep. 2019;9:1405 pubmed publisher
Plyler Z, Birket S, Schultz B, Hong J, Rowe S, Petty C, et al. Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats. Mech Dev. 2019;155:15-26 pubmed publisher
Barone T, Burkhart C, Safina A, Haderski G, Gurova K, PURMAL A, et al. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma. Neuro Oncol. 2017;19:186-196 pubmed publisher
Jain S, Stroopinsky D, Yin L, Rosenblatt J, Alam M, Bhargava P, et al. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood. 2015;126:354-62 pubmed publisher
Jain S, Jirau Serrano X, Zullo K, Scotto L, Palermo C, Sastra S, et al. Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma. Clin Cancer Res. 2015;21:2096-106 pubmed publisher
Lin J, Shen A, Chen H, Liao J, Xu T, Liu L, et al. Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways. BMC Cancer. 2014;14:729 pubmed publisher
Zhu K, Fang W, Chen Y, Lin S, Chen X. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer. Oncol Rep. 2014;32:1234-42 pubmed publisher
Ter Avetisyan G, Rathjen F, Schmidt H. Bifurcation of axons from cranial sensory neurons is disabled in the absence of Npr2-induced cGMP signaling. J Neurosci. 2014;34:737-47 pubmed publisher
Hua Y, White Gilbertson S, Kellner J, Rachidi S, Usmani S, Chiosis G, et al. Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma. Clin Cancer Res. 2013;19:6242-51 pubmed publisher
Lee S, Leoni G, Neumann P, Chun J, Nusrat A, Yun C. Distinct phospholipase C-? isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure. Mol Cell Biol. 2013;33:2016-28 pubmed publisher
Martin F, McKie P, Cataliotti A, Sangaralingham S, Korinek J, Huntley B, et al. Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection. Am J Physiol Regul Integr Comp Physiol. 2012;302:R292-9 pubmed publisher
Liu Y, Sun S, Owonikoko T, Sica G, Curran W, Khuri F, et al. Rapamycin induces Bad phosphorylation in association with its resistance to human lung cancer cells. Mol Cancer Ther. 2012;11:45-56 pubmed publisher
Chen T, Wang J, Hung S, Chu C, Cheng Y, Liang S. Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production. PLoS ONE. 2011;6:e23317 pubmed publisher
product information
master code :
4815-30-K
SKU :
4815-30-K
product name :
TumorTACS In Situ Apoptosis Detection Kit
unit size :
30 Tests
target :
TUNEL Assays
category :
Activity Assays
top caption :
TumorTACS In Situ Apoptosis Detection Kit_Mammary Tumor_4815-30-K
USD :
509 USD
storage :
The product requires storage at both -20 to -70 ░C and 2 - 8 ░C. Consult the product insert for specific storage temperatures.áDo not use past expiration date.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.